Bladder disturbances in multiple sclerosis and their management.
D001626:Bethanechol Compounds / Q000627:therapeutic use; D003558:Cystoscopy; D004326:Drinking; D006801:Humans; D007082:Ileum / Q000601:surgery; D008297:Male; D009103:Multiple Sclerosis / Q000150:complications*; D009119:Muscle Contraction; D014513:Ureter / Q000601:surgery; D014521:Urethra / Q000294:innervation; D001743:Urinary Bladder / Q000294:innervation; D001744:Urinary Bladder Calculi / Q000209:etiology; D001745:Urinary Bladder Diseases / Q000150:complications* / Q000628:therapy; D001748:Urinary Bladder Neck Obstruction / Q000209:etiology; D001750:Urinary Bladder, Neurogenic / Q000209:etiology; D014546:Urinary Catheterization / Q000009:adverse effects; D014547:Urinary Diversion; D014549:Urinary Incontinence / Q000628:therapy; D014552:Urinary Tract Infections / Q000209:etiology; D014554:Urination; D014718:Vesico-Ureteral Reflux / Q000209:etiology
D001626:Bethanechol Compounds